A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction
- PMID: 31277666
- PMCID: PMC6612106
- DOI: 10.1186/s12957-019-1656-y
A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction
Abstract
Background and aim: Endoscopic biliary drainage (EBD) and percutaneous biliary drainage (PTBD) are the two main strategies of preoperative biliary drainage (PBD) for resectable malignant biliary obstruction (MBO) worldwide, but which is better remains unclear. Seeding metastasis (SM) has been reported repeatedly in the recent decade, although it is rarely taken into consideration in the choice of PBD. Hence, a systematic review was badly warranted to evaluate the incidence of SM between PTBD and EBD in the preoperative treatment of MBO.
Methods: PubMed, MEDLINE, the Cochrane Library, and Web of Science were used to identify any potentially eligible studies comparing the incidence of SM between EBD and PTBD from Nov 1990 to Mar 2018. The effect size was determined by odds ratio (OR) with 95% confidence interval (CI).
Results: Ten studies were enrolled in this study, including 1379 cases in the EBD group and 1085 cases in the PTBD group. Results showed that the incidence of SM in the EBD group was significantly lower than that in the PTBD group (10.5% vs. 22.0%, OR = 0.35, 95% CI 0.23~0.53). Subgroup analysis stratified by the definition of SM showed that the pooled ORs for peritoneal metastasis and tube-related SM between EBD and PTBD were 0.42 (95% CI 0.31~0.57) and 0.17 (95% CI 0.10~0.29), respectively. Subgroup analysis stratified by the location of MBO showed that the pooled ORs for the incidence of SM between EBD and PTBD for perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer were 0.27 (95% CI 0.13~0.56), 0.32 (95% CI 0.17~0.60), and 0.27 (95% CI 0.19~0.40), respectively.
Conclusion: EBD should be the optimal PBD for MBO considering the SM, but it deserved further validation.
Keywords: Endoscope biliary drainage; Malignant biliary obstruction; Meta-analysis; Percutaneous biliary drainage; Preoperative biliary drainage; Seeding metastasis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1156-63. doi: 10.1245/s10434-015-4676-z. Epub 2015 Jun 30. Ann Surg Oncol. 2015. PMID: 26122370 Free PMC article.
-
Comparison of long-term efficacy between endoscopic and percutaneous biliary drainage for resectable extrahepatic cholangiocarcinoma with biliary obstruction: A systematic review and meta-analysis.Saudi J Gastroenterol. 2019 Mar-Apr;25(2):81-88. doi: 10.4103/sjg.SJG_429_18. Saudi J Gastroenterol. 2019. PMID: 30720001 Free PMC article.
-
Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.J Laparoendosc Adv Surg Tech A. 2018 Sep;28(9):1053-1060. doi: 10.1089/lap.2017.0744. Epub 2018 Mar 12. J Laparoendosc Adv Surg Tech A. 2018. PMID: 29641365
-
Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma.J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):533-40. doi: 10.1002/jhbp.76. Epub 2014 Jan 27. J Hepatobiliary Pancreat Sci. 2014. PMID: 24464984
-
Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma.J Gastroenterol. 2016 Jun;51(6):608-19. doi: 10.1007/s00535-015-1140-6. Epub 2015 Nov 9. J Gastroenterol. 2016. PMID: 26553053
Cited by
-
Acute cholangitis with Achromobacter xylosoxidans bacteremia after endoscopic retrograde cholangiopancreatography in hilar cholangiocarcinoma: A case report.World J Clin Cases. 2024 Jul 16;12(20):4377-4383. doi: 10.12998/wjcc.v12.i20.4377. World J Clin Cases. 2024. PMID: 39015928 Free PMC article.
-
Current Status of Endoscopic Biliary Drainage in Patients with Distal Malignant Biliary Obstruction.J Clin Med. 2021 Oct 8;10(19):4619. doi: 10.3390/jcm10194619. J Clin Med. 2021. PMID: 34640637 Free PMC article. Review.
-
Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters?Case Rep Oncol Med. 2020 May 9;2020:3738798. doi: 10.1155/2020/3738798. eCollection 2020. Case Rep Oncol Med. 2020. PMID: 32509367 Free PMC article.
-
Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.Semin Intervent Radiol. 2021 Aug;38(3):300-308. doi: 10.1055/s-0041-1731269. Epub 2021 Aug 10. Semin Intervent Radiol. 2021. PMID: 34393340 Free PMC article. Review.
-
Controversies in Endoscopic Ultrasound-Guided Biliary Drainage.Cancers (Basel). 2024 Apr 23;16(9):1616. doi: 10.3390/cancers16091616. Cancers (Basel). 2024. PMID: 38730570 Free PMC article. Review.
References
-
- Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) Nat Rev Gastroenterol Hepatol. 2016;13:261–280. doi: 10.1038/nrgastro.2016.51. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical